Blogs

May 07, 2018
Applied Clinical Trials
FDA officials are mapping plans to restructure the Office of New Drugs (OND) in the Center for Drug Evaluation and Research (CDER), writes Jill Wechsler.
May 02, 2018
Applied Clinical Trials
Provenance is at the heart of the discussion when it comes to the equation of privacy and provenance.
May 01, 2018
Applied Clinical Trials
The third in a series of results from the Center for Information and Study on Clinical Research Participation’s (CISCRP) landmark 2017 Perceptions & Insights Study.
May 01, 2018
Applied Clinical Trials
May includes a number of events to get more visibility for clinical trial awareness, and to offer it as a care option.
May 01, 2018
Applied Clinical Trials
Peter O’Donnell explores potential parallels of the U.S. “right-to-try” debate in Europe.
May 01, 2018
Applied Clinical Trials
Jill Wechsler interviews FDA Commissioner Scott Gottlieb about his push for more efficient R&D to help lower drug prices.
May 01, 2018
Applied Clinical Trials
BMS executive shares his perspectives on the current biomarker landscape, the role of translational medicine in accelerating this area of study, and how BMS is working to advance biomarker research across their R&D portfolio.
May 01, 2018
Applied Clinical Trials
Newest revelations suggest Risk Assessment Categorization Tools are now becoming therapeutic area-specific, as an oncology-based risk library is now surfacing.
Apr 27, 2018
Applied Clinical Trials
The British government continues to offer guarantees and reassurances about the post-Brexit future of its life-sciences sector despite the obvious failure so far to get even close to negotiating a withdrawal agreement with the EU.
Apr 27, 2018
Applied Clinical Trials
An additional light has been shone on the "right-to-try" debate in Europe by a strongly-worded statement from Belgium's feisty health minister, Maggie De Block.
native1_300x100
lorem ipsum